1. Home
  2. STRS vs EDIT Comparison

STRS vs EDIT Comparison

Compare STRS & EDIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stratus Properties Inc.

STRS

Stratus Properties Inc.

N/A

Current Price

$29.97

Market Cap

208.3M

Sector

Real Estate

ML Signal

N/A

Logo Editas Medicine Inc.

EDIT

Editas Medicine Inc.

HOLD

Current Price

$1.68

Market Cap

206.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STRS
EDIT
Founded
1992
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
208.3M
206.0M
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
STRS
EDIT
Price
$29.97
$1.68
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$4.50
AVG Volume (30 Days)
11.5K
1.8M
Earning Date
11-12-2025
03-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$31,912,000.00
$46,383,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.10
$0.91
52 Week High
$31.35
$4.54

Technical Indicators

Market Signals
Indicator
STRS
EDIT
Relative Strength Index (RSI) 65.14 31.81
Support Level $28.85 $1.92
Resistance Level $31.35 $2.11
Average True Range (ATR) 0.96 0.16
MACD 0.17 -0.02
Stochastic Oscillator 69.60 0.03

Price Performance

Historical Comparison
STRS
EDIT

About STRS Stratus Properties Inc.

Stratus Properties Inc is a diversified real estate company operating in the United States. It is engaged in the acquisition, entitlement, development, management, operation and sale of commercial, multi- and single-family residential real estate properties, located in the Austin Texas area and other select markets in Texas. It operates its business through two segments namely, Real Estate Operations and Leasing Operations. Real Estate Operations segment encompasses activities associated with entitlement, development, and sale of real estate. Leasing Operations segment involves leasing of commercial space at retail and mixed-use properties and residences in multi-family properties that company developed. Majority of revenue is from Real Estate Operations.

About EDIT Editas Medicine Inc.

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.

Share on Social Networks: